Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Orchard Therapeutics
2826
Orchard Therapeutics
Health Care
Technology
Biotechnology
Medical
Diagnostics
Health Diagnostics
Orchard Therapeutics is a biotechnology company
Suggest edits
Type
B2b
Founded
2015
Raised
$510.9M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
HSBC
DeepMind
Revolut
Volkswagen
Cambridge Analytica
Ubuntu
Companies in the same industry
myTomorrows
Phagelux
T2 Biosystems
CCG
Oxford Immunotec
GrandOmics
EndoChoice
GeneCentric Diagnostics, Inc.
Enterome Bioscience
Neurotrack
Alexa global traffic share
Overview
Funding
5
Add info
Add round
31 Oct
2018
$200,000,000
IPO
VC-backed Orchard Therapeutics goes public
PE HUB
+1
13 Aug
2018
$150,000,000
Venture capital (Series C)
RA Capital Management
,
Baillie Gifford
,
Perceptive Advisors
,
+13
Orchard Therapeutics Raises $150M in Series C Financing
FinSMEs
+1
20 Dec
2017
$110,000,000
Venture capital (Series B)
Temasek Holdings
,
Baillie Gifford
,
F-Prime Capital Partners
,
+9
| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters
PE HUB
23 Nov
2016
$20,000,000
Grant
California Institute for Regenerative Medicine
Orchard gets $20M to trial ‘bubble boy’ gene therapy
FierceBiotech
03 May
2016
£21,000,000
Venture capital (Series A)
F-Prime Capital Partners
Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies
b3cnewswire
